REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Closterpharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Closterpharma S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Closterpharma S.A. is based in Ecuador. The head office is in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on January 14, 2010. 3 (2021) employees currently work for Closterpharma S.A.. From the latest financial highlights, Closterpharma S.A. reported a net sales revenue increase of 145.97% in 2022. There was a total growth of 40.8% in Closterpharma S.A.’s total assets over the same period.

Headquarters
Inglaterra E3-263, Centro Ejecutivo Bldg. , Floor 602
Quito; Pichincha;

Contact Details: Purchase the Closterpharma S.A. report to view the information.

Website: http://www.closterpharma.com

Basic Information
Total Employees:
Purchase the Closterpharma S.A. report to view the information.
Outstanding Shares:
Purchase the Closterpharma S.A. report to view the information.
Registered Capital:
Purchase the Closterpharma S.A. report to view the information.
Incorporation Date:
January 14, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
68.74%
Purchase this report to view the information.
31.26%
Company Performance
Financial values in the chart are available after Closterpharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
145.97%▲
Total operating revenue
143.68%▲
Operating profit (EBIT)
N/A
EBITDA
906.68%▲
Net Profit (Loss) for the Period
N/A
Total assets
40.8%▲
Total equity
51.29%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.25%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo